Highnoon Laboratories Statistics

Total Valuation

Highnoon Laboratories has a market cap or net worth of PKR 48.23 billion. The enterprise value is 45.76 billion.

Market Cap	48.23B
Enterprise Value	45.76B

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Highnoon Laboratories has 52.98 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	52.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	41.30%
Owned by Institutions (%)	4.98%
Float	22.59M

Valuation Ratios

The trailing PE ratio is 15.97.

PE Ratio	15.97
Forward PE	n/a
PS Ratio	2.09
PB Ratio	4.45
P/TBV Ratio	4.46
P/FCF Ratio	11.64
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 11.04.

EV / Earnings	15.16
EV / Sales	1.99
EV / EBITDA	9.87
EV / EBIT	10.72
EV / FCF	11.04

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.11.

Current Ratio	2.69
Quick Ratio	1.52
Debt / Equity	0.11
Debt / EBITDA	0.25
Debt / FCF	0.28
Interest Coverage	15.60

Financial Efficiency

Return on equity (ROE) is 31.00% and return on invested capital (ROIC) is 24.81%.

Return on Equity (ROE)	31.00%
Return on Assets (ROA)	17.78%
Return on Capital (ROIC)	24.81%
Revenue Per Employee	10.03M
Profits Per Employee	1.32M
Employee Count	2,295
Asset Turnover	1.53
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +96.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+96.16%
50-Day Moving Average	871.26
200-Day Moving Average	706.83
Relative Strength Index (RSI)	52.53
Average Volume (20 Days)	41,812

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Highnoon Laboratories had revenue of PKR 23.02 billion and earned 3.02 billion in profits. Earnings per share was 56.98.

Revenue	23.02B
Gross Profit	11.64B
Operating Income	4.27B
Pretax Income	4.34B
Net Income	3.02B
EBITDA	4.52B
EBIT	4.27B
Earnings Per Share (EPS)	56.98

Full Income Statement

Balance Sheet

The company has 3.62 billion in cash and 1.15 billion in debt, giving a net cash position of 2.46 billion or 46.50 per share.

Cash & Cash Equivalents	3.62B
Total Debt	1.15B
Net Cash	2.46B
Net Cash Per Share	46.50
Equity (Book Value)	10.84B
Book Value Per Share	204.63
Working Capital	7.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.30 billion and capital expenditures -151.33 million, giving a free cash flow of 4.14 billion.

Operating Cash Flow	4.30B
Capital Expenditures	-151.33M
Free Cash Flow	4.14B
FCF Per Share	78.21

Full Cash Flow Statement

Margins

Gross margin is 50.57%, with operating and profit margins of 18.54% and 13.11%.

Gross Margin	50.57%
Operating Margin	18.54%
Pretax Margin	18.85%
Profit Margin	13.11%
EBITDA Margin	19.62%
EBIT Margin	18.54%
FCF Margin	18.00%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 3.30%.

Dividend Per Share	30.00
Dividend Yield	3.30%
Dividend Growth (YoY)	72.50%
Years of Dividend Growth	11
Payout Ratio	51.92%
Buyback Yield	n/a
Shareholder Yield	3.30%
Earnings Yield	6.26%
FCF Yield	8.59%

Dividend Details

Stock Splits

The last stock split was on June 16, 2023. It was a forward split with a ratio of 1.15.

Last Split Date	Jun 16, 2023
Split Type	Forward
Split Ratio	1.15

Scores

Highnoon Laboratories has an Altman Z-Score of 6.37.

Altman Z-Score	6.37
Piotroski F-Score	n/a